Heparin Sodium Injection — FDA Drug Shortage

Current — Fresenius Kabi USA, LLC

The FDA lists a drug shortage record for Heparin Sodium Injection (injection) from Fresenius Kabi USA, LLC with status Current. The shortage was first posted on Nov 14, 2017. Reported reason: Other

Shortage details

Status
Current
Company
Fresenius Kabi USA, LLC
Package NDC
63323-519-77
Dosage Form
Injection
Presentation
Heparin Sodium, Injection, 200 [USP'U]/100 mL (NDC 63323-519-77)
Initial Posting
Nov 14, 2017

Reason

Other

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.